These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 15704862

  • 1. Evaluation of different fast melting disintegrants by means of a central composite design.
    Di Martino P, Martelli S, Wehrlé P.
    Drug Dev Ind Pharm; 2005 Jan; 31(1):109-21. PubMed ID: 15704862
    [Abstract] [Full Text] [Related]

  • 2. Effect of disintegrants on the properties of multiparticulate tablets comprising starch pellets and excipient granules.
    Mehta S, De Beer T, Remon JP, Vervaet C.
    Int J Pharm; 2012 Jan 17; 422(1-2):310-7. PubMed ID: 22101283
    [Abstract] [Full Text] [Related]

  • 3. Application of a novel automatic disintegration apparatus for the development and evaluation of a direct compression rapidly disintegrating tablet.
    Jung HA, Augsburger LL.
    Drug Dev Ind Pharm; 2012 Jul 17; 38(7):825-36. PubMed ID: 22091970
    [Abstract] [Full Text] [Related]

  • 4. Application of general multilevel factorial design with formulation of fast disintegrating tablets containing croscaremellose sodium and Disintequick MCC-25.
    Solaiman A, Suliman AS, Shinde S, Naz S, Elkordy AA.
    Int J Pharm; 2016 Mar 30; 501(1-2):87-95. PubMed ID: 26827922
    [Abstract] [Full Text] [Related]

  • 5. An easy-to-use approach for determining the disintegration ability of disintegrants by analysis of available surface area.
    Iwao Y, Tanaka S, Uchimoto T, Noguchi S, Itai S.
    Int J Pharm; 2013 May 01; 448(1):1-8. PubMed ID: 23518366
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of binders in twin-screw wet granulation - Optimal combination of binder and disintegrant.
    Köster C, Kleinebudde P.
    Eur J Pharm Biopharm; 2023 May 01; 186():55-64. PubMed ID: 36913991
    [Abstract] [Full Text] [Related]

  • 7. Disintegration propensity of tablets evaluated by means of disintegrating force kinetics.
    Massimo G, Catellani PL, Santi P, Bettini R, Vaona G, Bonfanti A, Maggi L, Colombo P.
    Pharm Dev Technol; 2000 May 01; 5(2):163-9. PubMed ID: 10810746
    [Abstract] [Full Text] [Related]

  • 8. Disintegrant Selection in Hydrophobic Tablet Formulations.
    Bauhuber S, Warnke G, Berardi A.
    J Pharm Sci; 2021 May 01; 110(5):2028-2037. PubMed ID: 33181185
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of fast disintegrants in terfenadine tablets containing a gas-evolving disintegrant.
    Sallam E, Ibrahim H, Dahab RA, Shubair M, Khalil E.
    Drug Dev Ind Pharm; 1998 Jun 01; 24(6):501-7. PubMed ID: 9876615
    [Abstract] [Full Text] [Related]

  • 10. Performance of tablet disintegrants: impact of storage conditions and relative tablet density.
    Quodbach J, Kleinebudde P.
    Pharm Dev Technol; 2015 Jun 01; 20(6):762-8. PubMed ID: 24848093
    [Abstract] [Full Text] [Related]

  • 11. Development of a rapidly dispersing tablet of a poorly wettable compound: formulation DOE and mechanistic study of effect of formulation excipients on wetting of celecoxib.
    He X, Barone MR, Marsac PJ, Sperry DC.
    Int J Pharm; 2008 Apr 02; 353(1-2):176-86. PubMed ID: 18207339
    [Abstract] [Full Text] [Related]

  • 12. Functionality of wet-granulated disintegrant in comparison to directly incorporated disintegrant in a poorly water-soluble tablet matrix.
    Veronica N, Lee ESM, Heng PWS, Liew CV.
    Int J Pharm; 2024 Aug 15; 661():124467. PubMed ID: 39004293
    [Abstract] [Full Text] [Related]

  • 13. Influence of disintegrants in different substrate physical form on dimensional recovery of multi-component tablet.
    Sarkar S, Ooi SM, Liew CV, Tan BX, Heng PW.
    Int J Pharm; 2014 Nov 20; 475(1-2):558-65. PubMed ID: 25218488
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of coprocessed disintegrants produced from tapioca starch and mannitol in orally disintegrating paracetamol tablet.
    Adeoye O, Alebiowu G.
    Acta Pol Pharm; 2014 Nov 20; 71(5):803-11. PubMed ID: 25362809
    [Abstract] [Full Text] [Related]

  • 15. The effect of superdisintegrants on the properties and dissolution profiles of liquisolid tablets containing rosuvastatin.
    Vraníková B, Gajdziok J, Doležel P.
    Pharm Dev Technol; 2017 Mar 20; 22(2):138-147. PubMed ID: 26401959
    [Abstract] [Full Text] [Related]

  • 16. Preparation and evaluation of a compressed tablet rapidly disintegrating in the oral cavity.
    Bi Y, Sunada H, Yonezawa Y, Danjo K, Otsuka A, Iida K.
    Chem Pharm Bull (Tokyo); 1996 Nov 20; 44(11):2121-7. PubMed ID: 8945778
    [Abstract] [Full Text] [Related]

  • 17. Formulation and evaluation of nanocrystalline cellulose as a potential disintegrant.
    Wang C, Huang H, Jia M, Jin S, Zhao W, Cha R.
    Carbohydr Polym; 2015 Oct 05; 130():275-9. PubMed ID: 26076627
    [Abstract] [Full Text] [Related]

  • 18. Rational estimation of the optimum amount of non-fibrous disintegrant applying percolation theory for binary fast disintegrating formulation.
    Krausbauer E, Puchkov M, Betz G, Leuenberger H.
    J Pharm Sci; 2008 Jan 05; 97(1):529-41. PubMed ID: 17879295
    [Abstract] [Full Text] [Related]

  • 19. Development of Tablet Formulation of Amorphous Solid Dispersions Prepared by Hot Melt Extrusion Using Quality by Design Approach.
    Agrawal A, Dudhedia M, Deng W, Shepard K, Zhong L, Povilaitis E, Zimny E.
    AAPS PharmSciTech; 2016 Feb 05; 17(1):214-32. PubMed ID: 26757898
    [Abstract] [Full Text] [Related]

  • 20. Designing robust immediate release tablet formulations avoiding food effects for BCS class 3 drugs.
    Zaheer K, Langguth P.
    Eur J Pharm Biopharm; 2019 Jun 05; 139():177-185. PubMed ID: 30902732
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.